ASPC 2018 Congress on CVD Prevention
Avatar

Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a Seminal Transition in DM Management

By ASPC 2018 Congress on CVD Prevention FEATURING Mikhail Kosiborod
August 10, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

23:07
Novo Nordisk – GLP-1 RA Therapy

Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D:…

Feat. L. Coco, J. R. Gavin III

Featured Video

11:47
Lilly Diabetes

Getting Adult Patients With Type 2 Diabetes Started: Safety Profile …

Feat. E. Luna

Related Content

AUTOPLAY
21:22
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Obesity, Diabetes and Cancer Risk

Feat. D. LeRoith
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
22:19
Kenneth Margulies

GLP-1 Agonists for Diabetes

17:56
Cres Miranda

The CANVAS Trial - CANagliflozin cardioVascular Assessment Study

34:22
Cardiology Fiesta 2017

Changing Landscape of CV Treatment in Type 2 Diabetes

Feat. R. Chilton
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
17:35
Complex Coronary Valvular and Vascular Cases Conference

Diabetic Management to Reduce CV Events

20:55
Cleveland Clinic | 12th Annual Obesity Summit

What To Do After Metformin: GLP-1, SGLT2 or DPP-4?

Feat. K. Pantalone
11:47
Cardiometabolic Health Congress (CMHC)

Updated Type 2 Diabetes Guidelines

Feat. W. Lane
24:13
Cardiometabolic Health Congress (CMHC)

CVOT Trials for Type 2 Diabetes Treatment

Feat. R. Eckel
18:12
ASPC 2018 Congress on CVD Prevention

SESSION 3 - Cardiometabolic Discussion

24:44
ASPC 2018 Congress on CVD Prevention

Comprehensive Approach to Lowering CVD Risk in Diabetics

Feat. Y. Handelsman
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

14:31
UC Davis Health Diabetes and Endocrinology Symposium

Goals of Diabetes Treatment and Considerations in Selecting Diabetes…

Feat. J. Yoon
11:49
Cardiology Fiesta 2018

Changing Landscape of CV Treatment in Type 2 Diabetes

17:49
UC Davis Health Diabetes and Endocrinology Symposium

Effect of Diabetes Medications on the Kidney (and Heart)

Feat. S. Ananthakrishnan
09:04
UC Davis Health Diabetes and Endocrinology Symposium

Stepwise Therapy Versus Initial Combination Therapy in Diabetes

Feat. J. Yoon
14:29
UC Davis Health Diabetes and Endocrinology Symposium

Mixing and Matching Antidiabetic Medications: What's the Best C…

Feat. J. Yoon
18:02
3rd National Conference On Prevention Of Diabetes

CVD Outcome Trials in T2DM: GLP-1 Receptor Agonists

Feat. P. Gaede